The company develops a chronic-pain digital therapy solution that blends automated algorithms with clinician oversight, creating a "human-machine" care model aimed especially at the ageing population. Its platform delivers personalised pain-management programs through mobile and remote channels, allowing patients to access evidence-based exercises, behavioural coaching and continuous monitoring. The product has earned clinical recognition from Mayo Clinic, underscoring its medical credibility. Positioned within the fast-growing ‘active ageing’ market, the firm seeks to address the rising prevalence of musculoskeletal and neuropathic pain among seniors. The company plans to expand both its clinical evidence base and market reach, leveraging the recent capital to scale product development and distribution. Financially, it has just closed an USD 11 million fundraising, but no revenue or user metrics were disclosed in the article. Future initiatives will likely focus on deepening AI capabilities and forging additional healthcare-provider partnerships.

Total raised

$11M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2025